Clinical Trial Update: A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD [Phase 1]

View source ↗

Summary

This clinical trial update notes completion of a Phase 1 study evaluating the safety, tolerability, ciliary rescue, and pharmacodynamics of RCT1100 in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ciliary Dyskinesia

Drugs mentioned

• RCT1100

Snippet

Sponsor: ReCode Therapeutics | Conditions: Primary Ciliary Dyskinesia | Phase 1 | Status: COMPLETED